S-DUAL
Live / Registered — Registered (as of 05 Aug 2025)
What this means for you
Registered since 05 Aug 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79365471
- Registration number
- 7876915
- Mark type
- Stylized text
- Filed
- 31 Jan 2023
- Published for opposition
- 17 Jun 2025
- Registered
- 05 Aug 2025
- Attorney of record
- Brian P. Gregg
Goods and services
- Class 001 — Chemicals: Multiple fusion proteins in raw material form for scientific or medical research use; diagnostic reagents for scientific or research use; enzymes for scientific or research purposes; bispecific antibody being monoclonal antibodies for in vitro scientific or medical research use; cell culture reagents for scientific and research use; monoclonal antibodies for in vitro scientific purposes; microorganisms for scientific or laboratory purposes, other than for medical and veterinary use; biological preparations for scientific or industrial laboratory purposes; fusion proteins in raw material form for scientific or medical research laboratory purposes; polymerase for nucleic acid for scientific or laboratory purposes; biochemical preparations for scientific purposes; double antibody reagents for scientific purposes; double antibody reagents for scientific purposes in biotechnological product development; biological preparations for use in biotechnology, other than for medical and veterinary use; biochemical catalysts; chemical reagents for use in genetic research for non-medical purposes
- Class 005 — Pharmaceuticals: Reagents for measurement of HBs antibody for medical purposes; crude medicines for the treatment of cardiovascular diseases; pharmaceutical preparations for activating cellular function; colostral antibodies for veterinary purposes; chemico-pharmaceutical preparations for treating ocular diseases; chemical preparations for use in DNA analysis for medical purposes; bacterial preparations for medical and veterinary use; chemical preparations for medical or veterinary purposes, namely, for bispecific or multispecific antibodies and derivatives thereof, to treat cancers, inflammatory diseases, autoimmune diseases, infectious diseases and cardiovascular diseases, neurological disorder and for related diagnostic or therapeutic use, and for use in related assays; biotechnological preparations being reagents for medical purposes; biological reagents for medical purposes; biochemical preparations for medical use, namely, for bispecific or multispecific antibodies and derivatives thereof, to treat cancers, inflammatory diseases, autoimmune diseases, infectious diseases and cardiovascular diseases, neurological disorder and for related diagnostic or therapeutic use, and for use in related assays; reagents for medical use; reagent paper for medical purposes; bispecific colostral antibody for medical purposes; medical diagnostic test strips for use in the field of blood analysis; trace element preparations for human use, namely, dietary and nutritional supplements; clinical medical reagents; therapeutic drugs for treating cancer and drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; antigens being pharmaceutical preparations for stimulating immune responses; colostral antibodies for medical purposes
- Class 042 — Scientific and technological services: Research relating to science, namely, scientific research; multiple nucleic acid scientific analysis; molecular scientific analysis; development of biotechnology; biochemical analysis; drug discovery services; new product design services; pharmaceutical research and development; clinical research in the field of medicine; services for assessing the efficiency of pharmaceuticals, namely, product quality testing; fusion protein scientific analysis; computer programming services in the medical field; medical laboratories; computer project management services relating to imaging medical data; medicine research being medical research; analysis and evaluation of medical product development, namely, product quality testing; providing scientific information on the testing, inspection and research of medical products; scientific laboratory services relating to the production of bispecific antibody; drug development of bispecific antibody; scientific research and development for double antibody reagent; evaluating of clinical trial progress, namely, conducting clinical trials for others; conducting clinical trials for others
Owner
Prosecution history
- 05 Mar 2026 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 12 Feb 2026 — FINAL DISPOSITION NOTICE SENT TO IB
- 12 Feb 2026 — FINAL DISPOSITION PROCESSED
- 05 Nov 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 05 Aug 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 Aug 2025 — REGISTERED-PRINCIPAL REGISTER
- 17 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Jun 2025 — PUBLISHED FOR OPPOSITION
- 11 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 May 2025 — EXAMINER'S AMENDMENT ENTERED
- 15 May 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 15 May 2025 — EXAMINERS AMENDMENT E-MAILED
- 15 May 2025 — EXAMINERS AMENDMENT -WRITTEN
- 06 May 2025 — ASSIGNED TO EXAMINER